Jane Wright-Mitchell - 16 Aug 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
General Counsel
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
16 Aug 2021
Net transactions value
-$59,925
Form type
4
Filing time
18 Aug 2021, 18:02:03 UTC
Previous filing
16 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $5,075 +2,500 +80% $2.03* 5,625 16 Aug 2021 Direct
transaction PCVX Common Stock Sale $65,000 -2,500 -44% $26.00 3,125 16 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -2,500 -1.3% $0.000000 187,468 16 Aug 2021 Common Stock 2,500 $2.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.